Eye make-up causing vision problems in young women

Agencies
July 13, 2017

New Delhi, Jul 13: Meibomian gland dysfunction -- also known as dry eye syndrome -- is on the rise among women due to excess make-up of the eyes. Though not taken seriously, the condition leads to blepharitis, extreme blurred vision, said doctors.Eye

Latest medical cases revealed that though MGD until now was seen due to ageing, now the trend has changed and it is occurring among young women as well.

"The changing trend of make-ups causing MGD is dangerous. Eyeliner and other make-up usually clog the meibomian glands leading to formation of painless lumps in the eyelids hence obstructing the vision," said Mahipal Sachdev, Director, Centre for Sight, a chain of eye centres in North India.

Elaborating on the condition, Sachadev, who often sees young women with MGD says that the meibomian produce oils that prevent the tears from evaporating quickly. Whenever the glands do not function properly, the blockage in the gland restricts it from producing oil.

"The oil may sometimes thicken leading to cause benign lumps in the eyelids known as chalazion. MGD is the most known and leading cause of dry eye syndrome, blepharitis and in extreme cases loss of vision," said Sachdev.

Medical Sciences says that there are around 40 such glands that produce oil that flows out of the eyes as tears to keep the eyes moistened. Thickening of this oil restricts its flow causing accumulation and blockage, forming a lump in the eyelid. A blocked oil gland causes this condition of red swollen eyelids.

"Around 40 per cent of the women with high usage of eye make-up products tend to get affected with oil gland blockages. Parabens and yellow wax used in mascara and eyeliners to stiffen them to make it waterproof are the same chemicals that also clog the oil glands leading to MGD, chalazion, dry eye syndrome and blepharitis," Parul Sony, senior consultant and director of Gurgram's Complete Eye Care.

Stating that anti-ageing eye creams contain retinoids that has also been linked to thickening and degeneration, Sony said that such make-ups kill the blood cells in the meibomian gland ducts.

A study by Canada's University of Waterloo said people who apply eyeliner on the inner eyelid run the risk of contaminating the eye and causing vision trouble.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
May 26,2020

Tedros Adhanom Ghebreyesus, the World Health Organisation's (WHO) Director-General, said that a clinical trial of hydroxychloroquine (HCQ) on COVID-19 patients has come to "a temporary pause", while the safety data of the the anti-malaria drug was being reviewed.

According to the WHO chief, The Lancet medical journal on May 22 had published an observational study on HCQ and chloroquine and its effects on COVID-19 patients that have been hospitalized, reports Xinhua news agency.

The authors of the study reported that among patients receiving the drug, when used alone or with a macrolide, they estimated a higher mortality rate.

"The Executive Group of the Solidarity Trial, representing 10 of the participating countries, met on Saturday (May 23) and has agreed to review a comprehensive analysis and critical appraisal of all evidence available globally," Tedros said in a virtual press conference on Monday.

The review will consider data collected so far in the Solidarity Trial and in particular robust randomized available data, to adequately evaluate the potential benefits and harms from this drug, he said.

"The Executive Group has implemented a temporary pause of the HCQ arm within the Solidarity Trial while the safety data is reviewed by the Data Safety Monitoring Board. The other arms of the trial are continuing," Tedros added.

WHO initiated the Solidarity Trial, a plan to evaluate the safety and efficacy of four drugs and drug combinations against COVID-19 more than two months ago, which include HCQ.

According to the WHO, over 400 hospitals in 35 countries are actively recruiting patients and nearly 3,500 patients have been enrolled from 17 countries under the Solidarity Trial.

Tedros added that the safety concern over the drug related only to the use of HCQ and chloroquine in COVID-19, and "these drugs are accepted as generally safe for use in patients with autoimmune diseases or malaria".

"WHO will provide further updates as we know more," he added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
June 23,2020

The record levels of new daily COVID-19 cases are due to the fact that the pandemic is peaking in a number of big countries at the same time and reflect a change in the virus' global activity, the World Health Organisation said.

At a media briefing on Monday, WHO's emergencies chief Dr Michael Ryan said that the numbers are increasing because the epidemic is developing in a number of populous countries at the same time.

Some countries have attributed their increased caseload to more testing, including India and the US But Ryan dismissed that explanation.

We do not believe this is a testing phenomenon, he said, noting that numerous countries have also noted marked increases in hospital admissions and deaths neither of which cannot be explained by increased testing.

There definitely is a shift in that the virus is now very well established, Ryan said. The epidemic is now peaking or moving towards a peak in a number of large countries.

He added the situation was definitely accelerating in a number of countries, including the US and others in South Asia, the Middle East and Africa.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.